Evidence map›Paper›PMID 35948778›Full record

Trial reportNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Ketogenic diet in refractory migraine: possible efficacy and role of ketone bodies-a pilot experience.

Carlo Lovati, Caterina Mariotti d'Alessandro, Stefania Della Ventura, Fulvio Muzio, Leonardo Pantoni

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Migraine Management in Medically Complex Patients: a Narrative Review.Current neurology and neuroscience reports · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Carlo LovatiHeadache Center, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi 74, 20156, Milan, Italy. carlo.lovati@asst-fbf-sacco.it.ORCID http://orcid.org/0000-0002-7885-1513
Caterina Mariotti d'AlessandroHeadache Center, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi 74, 20156, Milan, Italy.
Stefania Della VenturaEndocrinology Unit, Humanitas Clinical and Research Institute - IRCCS, Rozzano, MI, Italy.
Fulvio MuzioClinical Nutrition and Dietetics Unit, L, Sacco University Hospital, Milan, Italy.
Leonardo PantoniLuigi Sacco, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Luigi Sacco Hospital · ITHumanitas University · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRefractory migraine is a particularly disabling form of chronic migraine, unresponsive to multiple prophylactic strategies. Ketogenic diet (KD) is useful to treat migraine but poorly tested for refractory migraine.

objectiveWe started exploring the efficacy and safety of KD, as compared to a non-ketogenic dietary regimen similar in reduction of carbohydrate intake (low-carb diet, LCD), in refractory migraine. Secondary objective was to explore whether ketones have a role in the prophylaxis induced by KD on migraine.

resultsIn a first trial, 22 patients with refractory migraine were included and completed the study. Thirteen (mean age 36.8 ± 12.9 years, 11 females, 2 males) were assigned to the KD arm and eight (mean age 50.9 ± 10.8 years; all females), not eligible for KD, to LCD. Patients treated with KD showed a significant reduction in the frequency of migraine attacks, intensity of headache, and amount of drug intake. No significant benefit was seen in the LCD group. A relationship between ketone production and effect on headache was observed among patients with a good response to KD. In a second study, additional 31 refractory migraineurs were treated with these two dietary regimens, 26 with the same KD scheme and 5 with a LCD. Results were comparable with those of the first study.

conclusionsKD might be a useful option in refractory migraine. Ketones seem to have a role in migraine modulation and their regular measurement might be useful to monitor KD in migraineurs. Larger, randomized, and controlled trials are needed to confirm these data.

Indexed as

Diet, KetogenicMigraine DisordersAdultAnalgesicsFemaleHeadacheHumansKetone BodiesMaleMiddle AgedYoung AdultAnalgesicsKetone BodiesDietKetoneMigraineProphylaxisRefractory migraineTreatment

Identifiers

PMID35948778
OpenAlexW4291020206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.